Abstract

Studies have shown a shift in the prevalence from Gram-positive to Gram-negative bacteraemia in patients with haematological malignancies who develop febrile neutropenia. There are also reports on the spread of drug resistant bacteria among these patients. Information about locally prevalent bacteria and their resistance is important to guide empirical therapy. The aim of this study was to characterise the bacterial spectrum and antibiotic resistance pattern of bacteraemia in neutropenic patients with haematological malignancies METHODOLOGY: In this retrospective study, patients admitted to Haematology and Oncology units over a period of 6 months with laboratory-confirmed positive blood cultures were enrolled. Information regarding demographic profile, clinical features, and microbiological profile were recorded. Standard procedures were applied to identify the isolates and their resistance patterns. The data collected was analysed statistically. 56 isolates from 53 patients were isolated of which majority were gram negative bacilli (GNB; n = 52 or 93%). Klebsiella pneumoniae (43%, n = 24) was the most frequently isolated bacteria followed by Enterobacter sp (20%, n = 11) and Escherichia coli (12%, n = 7). All isolates were susceptible to colistin. Susceptibility to cefaperazone-sulbactam, piperacillin-tazobactam and carbapenems were 32%, 28.6% and 26.8% respectively. The outcome was fatal for 25 patients. The study documented an alarming rise in the prevalence of GNB and their resistance. Though the results of the study may represent only the tip of the iceberg, the results demonstrate the need for treatment options for drug resistant isolates and for surveillance cultures.

Highlights

  • Studies have shown a shift in the prevalence from Gram-positive to Gram-negative bacteraemia in patients with haematological malignancies who develop febrile neutropenia

  • Bloodstream infections (BSIs) are an important cause of mortality and morbidity in febrile neutropenic patients with haematological malignancies

  • Studies have documented a shift in prevalence from Gram-positive to gram negative bacteraemia as well as the rise and spread of drug resistant bacteria in these patients

Read more

Summary

Introduction

Studies have shown a shift in the prevalence from Gram-positive to Gram-negative bacteraemia in patients with haematological malignancies who develop febrile neutropenia. Bloodstream infections (BSIs) are a major cause of morbidity and mortality in cancer patients These infections occur frequently in patients who develop febrile neutropenia (FN) during chemotherapy and after bone marrow transplant [1]. Several studies have reported a shift in prevalence from Gram-positive to Gram negative bacteraemia [2]. Accompanying this shift is the rise and successful dissemination of multi drug resistant (MDR), extensively drug resistant (XDR) and pan drug resistant (PDR) gram negative bacteria [4]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call